Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 2,587 shares at $57.51 ($149K) on 2025-02-11, disclosed to the SEC on 2025-02-11.
Scheduled sale ($149k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.51 | 1,291 | $74K | 49.9% |
| 2 | $57.51 | 1,291 | $74K | 49.9% |
| 3 | $57.53 | 5 | $288 | 0.2% |
| Total | $57.51 avg | 2,587 | $149K | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |